1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Adenocarcinoma Of Kidney in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerman, OC; Corstens, FH; Dijkgraaf, I; Kruijtzer, JA; Liskamp, RM; Liu, S; Oyen, WJ; Soede, AC | 1 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Chelating Agents; Cross-Linking Reagents; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2007 |